Exclusive: Advent in the lead to buy inVentiv for close to $4 billion – sources

(Reuters) – Private equity firm Advent International is in advanced talks to acquire inVentiv Group Holdings in a deal that could value the U.S. pharmaceutical research firm at close to $4 billion,…

Leave a Reply

Read the original at Reuters: Deals.